1-5 of 5
Hamid Hoorfar
Close
Sort by
Journal Articles

Prospective Observation on the Use of Von Willebrand Factor (VWF) Concentrates in a Large Cohort of Type 3 Von Willebrand Disease (VWD): Interim (18-months) Analyses on 149 Cases Enrolled into the 3Winters-Ips Project

Augusto B Federici, MD, Zahra Badiee, Mohammad-Reza Baghaipour, Giancarlo Castaman, Peyman Eshghi, MD, Jenny Goudemand, MD PhD, Charles RM Hay, MD, Hamid Hoorfar, MD, Mehran Karimi, MD, Bijan Keikhaei, Riitta Lassila, MD PR, Frank Leebeek, Maria Fernanda Lopez Fernandez, Renato Marino, Ian Peake, PhD, Rafael Parra Lòpez, Flora Peyvandi, MD PhD, Cristina Santoro, MD PhD, Simona Maria Siboni, Alberto Tosetto, Marc Trossaert, Jeroen C.J. Eikenboom, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2464.
https://doi.org/10.1182/blood-2018-99-112447
Published: 2018
Journal Articles

Clustering of Bleeding Symptoms in Patients Previously Diagnosed As Type 3 Von Willebrand Disease: Results from a Large Cohort of Type 3 Von Willebrand Disease (the 3Winters-Ips Project)

Alberto Tosetto, Zahra Badiee, Mohammad-Reza Baghaipour, Luciano Baronciani, PhD, Javier Battle, Erik Berntorp, MD PhD, Imre Bodó, MD PhD, Ulrich Budde, MD, Giancarlo Castaman, Jeroen C.J. Eikenboom, MD, Peyman Eshghi, MD, Cosimo Ettorre, MD, Anne Goodeve, PhD, Jenny Goudemand, MD PhD, Charles Richard Morris Hay, MD FRCP, FRCPath, Hamid Hoorfar, MD, Mehran Karimi, MD, Bijan Keikhaei, Riitta Lassila, MD PR, Frank W.G. Leebeek, MD PhD, Maria Fernanda Lopez Fernandez, Pier Mannuccio Mannucci, Maria Gabriella Mazzucconi, MD, Massimo Morfini, Johannes Oldenburg, Ian Peake, PhD, Rafael Parra Lòpez, Flora Peyvandi, MD PhD, Reinhard Schneppenheim, MD PhD, Andreas Tiede, MD, Gholamreza Toogeh, Marc Trossaert, Omidreza Zekavat, MD, Eva M.K. Zetterberg, MD PhD, Augusto B Federici, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2465.
https://doi.org/10.1182/blood-2018-99-113996
Published: 2018
Journal Articles

Profile of Mutations Identified in the 3WINTERS-IPS Project on European & Iranian Patients with Previously Diagnosed Type 3 Von Willebrand Disease.

Luciano Baronciani, PhD, Flora Peyvandi, MD PhD, Anne Goodeve, PhD, Reinhard Schneppenheim, MDPhD, Zahra Badiee, Mohammad-Reza Baghaipour, Javier Battle, Erik Berntorp, MD PhD, Imre Bodó, MD PhD, Ulrich Budde, MD, Andrea Cairo, PhD, Giancarlo Castaman, Laura Crookes, Jeroen C.J. Eikenboom, MD, Peyman Eshghi, MD, Cosimo Ettorre, MD, Jenny Goudemand, MD PhD, Wolf Hassenpflug, Charles Richard Morris Hay, MDFRCP,FRCPath, Hamid Hoorfar, MD, Mehran Karimi, MD, Bijan Keikhaei, Riitta Lassila, MD PR, Frank W.G. Leebeek, MD PhD, Maria Fernanda Lopez Fernandez, Pier Mannuccio Mannucci, MD, Maria Gabriella Mazzucconi, MD, Massimo Morfini, MD, Nikolas Nikšić, Johannes Oldenburg, Florian Oyen, Rafael Parra Lòpez, Ian Peake, PhD, Gholamreza Toogeh, Alberto Tosetto, Marc Trossaert, Sayed Omid Reza Zekavat, MD, Eva M.K. Zetterberg, MD PhD, Augusto B Federici, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1184.
https://doi.org/10.1182/blood-2018-99-114702
Published: 2018
Journal Articles

A Comparison of Efficacy Between Recombinant Activated Factor VII (ARYOSEVEN TM ) and NOVOSEVEN® in Patients with Hereditary FVIII Deficiency with Inhibitor

Mohammad Faranoush, Hassan Abolghassemi, Gh Toogeh, Mehran Karimi, Peyman Eshghi, M Managhchi, MD, Hamid Hoorfar, Dehdezi B Keikhaei, B Mehrvar, Babak Khoein, K Kaymar, R Heshmat, Mohammad Baghaeipour, NB Mirbehbahhani, R Fayazfar, Majid Naderi, Minoo Ahmadinejad, F Mahbodi, Behrooz Vaziri
Journal: Blood
Blood (2014) 124 (21): 4299.
https://doi.org/10.1182/blood.V124.21.4299.4299
Published: 2014
Journal Articles

Successful Delivery of Patients with FXIII Deficiency on Prophylaxis in Iran

Majid Naderi, Peyman Eshghi, Nader Cohan, Minoo Yaghmaei, Ebrahim Miri Moghaddam, Simin Sadeghi-Bojd, Mehran Karimi, MD, Hamid Hoorfar, Manijeh Lak, MD, Behzad Narouie
Journal: Blood
Blood (2011) 118 (21): 4363.
https://doi.org/10.1182/blood.V118.21.4363.4363
Published: 2011